Ford Motor Company is on a mission like no other time in its history to improve the customer experience from the dealerships on up. The driving force behind this mission is a current Ford executive, a forward thinker, a woman, and a member of the Ford family.
Elena A. Ford served the company as a Vice President until October of 2018, at which time she was promoted to a new role. Elena’s new position became official on November 1, and she is now the Chief Customer Experience Officer at Ford. Her accomplishments as VP have already helped to innovatively mark Ford’s place as a leading brand going into the future. In her new role, Elena works with the Ford dealers around the world to establish a new level of customer service and the entire buying experience. This is a newly created position in the organization. Elena Ford now reports directly to Joe Hinrichs, a top level Ford executive who currently serves as the President of Global Operations.
As the great-great-granddaughter of Ford Motor Company founder Henry Ford, Elena Ford has her own vision for the company as did her gifted ancestor before her. She strives to fulfill her vision for “No-Stress Driving and Car Ownership” for their valued customers. Elena”s grandfather is Henry Ford II, Ford’s current President. Her parents are Charlotte Ford and Stavros Niarchos. Elena is a graduate of New York University. She was born in May of 1966 in New York City.
Ford Motor Company is an American company, and it trades on the New York Stock Exchange. It was in 1903 that entrepreneur Henry Ford launched his company. Ford Motor now employees over 200,000 people worldwide. The company manufactures cars, SUVs, and a fleet of trucks and commercial vehicles under the brand names of Ford and previously Mercury, Jaguar, and Land Rover. The company is ranked as the second largest American auto maker, and globally it is the fifth largest. Ford’s headquarters are in Dearborn, Michigan.
Elena Ford undertakes her new position with the passion to reach new levels of customer satisfaction for the company. She was largely instrumental in the launch of the FordPass app. She understands the challenges and the opportunities that belie the automotive industry, Elena has proven herself to be a highly competent executive leader, and the company and its employees expect good things for Ford Motor Company in the future.
Women who suffer from pelvic floor disorders finally have a reason to smile, especially after Renovia Inc. announced the close of $42.3 million financing. This included the $32.3 million in the Series B equity and another one for $10 million in venture debt. Renovia Inc is a company that is keen on discovering and also delivering devices for women suffering from pelvic floor disorders. It was co-founded by Marc Beer along with Ramon Iglesias and Yolanda Lorié. The proceeds from the funding will go a long way to support the company’s product development pipeline, clinical trials, its development as well as future commercial launches.
The Series B financing was led by Perceptive Advisors and Ascension Ventures. Other companies in attendance included Inova Strategic Investments, Longwood Fund, Cormorant Asset Management, OSF Ventures and also Western Technology Investment. BayCross Capital Group was an advisor to Renovia Inc.
In a statement, Renovia Inc CEO Mr. Marc Beer said that they were thrilled by the king of support they received from a group of renowned healthcare investors with the same vision of better diagnosing, treating as well as improving the lives of millions of women in the world suffering from pelvic floor disorders. He added that the presence of the new and existing financial investors along with the three leading integrated health networks whom the company can partner with is in line with Renovia’s clinical as well as commercial vision.
He said that combining the company’s innovative and proprietary sensor technologies and the forming factors with a digital health platform will ensure that customers get accurate data and open ways to new treatment options. This will also help drive great knowledge and understanding of these disorders and hence lower long-term treatment costs. The funding recognizes the incredible value of Renovia’s innovative digital therapeutic as well as diagnostic product pipeline that is soon set to be brought to the treatment of pelvic floor disorders such as urinary incontinence.
Research shows that Urinary incontinence is a global condition that affects more than 250 million women the world over. Since its inception in 2016 Revonia Inc has been very vocal and committed to developing a product line diagnostic potential and therapeutic product for curing these disorders and restoring the health of the affected women. The company’s first product called Leva was cleared by the FDA last April.
About Marc Beer
Marc Beer is the co-founder and CEO of the Boston Based Biotech startup Renovia. He has extensive skills and expertise to lead this company. In the past, Mr. Beer worked in the business sales, development and also in pharmaceuticals for a whopping 25 years. He even worked in a number of sales roles with Abbott laboratories.
Later on, he founded ViaCell, a successful company that uses human cells for curing uncommon diseases. Ever since he was in college, he was concerned with the health issues of women and best solutions. To date, even as he is CEO, he is making the dream a reality. Learn more: https://www.bizjournals./boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.htmlcom
In 1987 Marc Beer walked out of the University of Miami with a Bachelor’s of Science Degree and he never looked back. Instead, he focused on biotechnology, pharmaceuticals, devices, and diagnostics with a specialization in developing these further and commercializing them so the consumer understood how it would make both their lives and the lives of their children better.
One of his biggest accomplishments includes becoming the founding CEO of ViaCell, which specializes in preserving stem cells from umbilical cords. He not only kept the company growing but made it thrive.
And now he’s using his company Renovia Inc. to help the pelvic floor at Boston Women’s Health. This plan cost about thirty-two million dollars in Series B along with ten million in venture debt. The exciting thing about this venture with Boston Women’s Health is that the money will be spent with the goal to improve the lives of women in the community who struggle with silent disorders. With the money, they are developing both diagnostic and therapeutic products to help people with issues such as urinary incontinence. Urinary incontinence is a problem that affects two hundred and fifty million women worldwide. The venture’s first product received FDA approval in April, giving women who are already in Boston Women’s some relief already.
Several companies saw and believed in what Renovia Inc. was doing and backed them up. These companies include the Longwood Firm, New York’s Perceptive Advisors, and Missouri’s Ascension Ventures. Their funding will help further the goal of relief by testing out four more diagnostic and therapeutic products, including a new generation of the Leva device.
The Leva device is a digital health program that uses Bluetooth to give interactive visualization to women, giving them real-time progress tracking, helping them strengthen and rehabilitate weak pelvic muscles. It does this without surgery or medicine.
Marc Beer stated that the goal for the funding and devices is to, “give our customers valuable data to inform new treatment options, drive greater knowledge and understanding of pelvic floor disorders, and ultimately lower long-term healthcare costs.” Something, it seems, everyone can get behind. Learn more: https://www.slideshare.net/MarcBeer